NCT02661048View on ClinicalTrials.gov

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 27, 2015

Primary Completion Date

July 6, 2023

Study Completion Date

July 6, 2023

Conditions
Tachycardia, Ventricular
Interventions
DEVICE

CyberHeart System

The CyberHeart system uses proprietary software to assist the cardiologist to contour ablation targets. Standard radiosurgical techniques are then used to accomplish ablation

Trial Locations (1)

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY

NCT02661048 - CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation | Biotech Hunter | Biotech Hunter